Clinical Bioanalysis
Inotiv delivers comprehensive clinical bioanalytical services designed to support your molecule through clinical development to regulatory approval. Every clinical program is unique, and our team partners with you to build a scientifically rigorous, regulatory-compliant bioanalytical strategy tailored to your compound, modality and study design.
During early clinical development, you gain critical insights into your compound’s behavior in human matrices, enabling refinement of PK/PD models and identification of biomarkers that guide clinical decision-making.
In the regulated pathway, our team develops and validates methods aligned with FDA, EMA, and ICH M10 guidance, providing robust, defensible data that advances your program with confidence.



